Novartis Services, Inc.

Registered Principal Details

Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.

Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.

CEO Name:
Vas Narasimhan

Contact
CF
Candice Finnegan
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(908) 210-1962
candie.finnegan@novartis.com
http://www.novartis.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 744
Assembly Bill 744
Relating to: rare disease advisory council. (FE)

Bill Text and History

For
Notification Date
1/12/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Senate Bill 689
Relating to: rare disease advisory council. (FE)

Bill Text and History

For
Notification Date
11/19/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2021
January - June
2021
July - December
2022
January - June
Total
Total Lobbying Expenditures 2021
January - June
$0.00
2021
July - December
$0.00
2022
January - June
$2,412.00
Total $2,412.00
Total Hours Communicating 2021
January - June
0.00
2021
July - December
0.00
2022
January - June
0.00
Total 0.00
Total Hours Other 2021
January - June
0.00
2021
July - December
0.00
2022
January - June
6.00
Total 6.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
100 %
2022
July - December
Total 100 %

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
100 %
2021
July - December
100 %
2022
January - June
2022
July - December
Total < 1%

Filed Statements of Lobbying Activity and Expenditures